LP
MDLN

Lexington Partners’s Medline Inc MDLN Stock Holding History

Lexington Partners’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-134,232
Closed -$5.97M – 3
2026
Q1 		$5.97M Hold
134,232
– – 1.63% 2
2025
Q4 		$5.64M Buy
+134,232
New +$5.67M 1.66% 3

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Lexington Partners's MDLN Position: Q2 2026 in Review

Lexington Partners sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 134,232 shares — an estimated $5.97M sold.

Lexington Partners first reported a position in MDLN in Q4 2025 and held it in 2 quarters. The position peaked at $5.97M in Q1 2026. 280 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Lexington Partners reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
  • Lexington Partners sold 134,232 Medline Inc shares in Q2 2026, an estimated $5.97M.
  • Lexington Partners first reported a position in Medline Inc in Q4 2025 and held it in 2 quarters.
  • Lexington Partners's Medline Inc position peaked at $5.97M in Q1 2026.
  • 280 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Lexington Partners's 13F filing for Q2 2026, filed 7 Aug 2026.